Diabetes Management - Lowering Cardiovascular Risk

被引:0
|
作者
Gaita, Dan [1 ]
Mosteoru, Svetlana [1 ]
Sperling, Laurence [2 ]
机构
[1] Victor Babes Univ Med & Pharm Timisoara, Inst Cardiovasc Med Timisoara, Cardiol Dept, Pta Murgu Eftimie 2, Timisoara 300041, Romania
[2] Emory Univ, Sch Med, Heart Dis Prevent Ctr, Atlanta, GA USA
关键词
Diabetes mellitus; cardiovascular risk; risk factors; glycaemic control; microvascular complications; macrovascular complications;
D O I
10.15420/ecr.2014.9.1.7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus is one of the most common diseases to plague the present day. Sixty percent of mortality in diabetic patients is caused by coronary artery disease. Numerous studies have shown that improving glycaemic control helps manage microvascular complications. On the other hand, some studies have shed light on the fact that a too tight glycaemic control can have adverse effects, especially on patients with high cardiovascular risk. Thus 'the lower the better' attitude should be exchanged for 'the earliest the best' attitude. A multidisciplinary approach should therefore be undertaken in order to achieve a proper management of the cardiovascular risk for diabetic patients. This includes using hypoglycaemic agents, antihypertensive medication and statins to balance the myriad of cardiovascular risk factors.
引用
收藏
页码:7 / 9
页数:3
相关论文
共 50 条
  • [1] Cardiovascular Risk Management in Diabetes Patients
    Kim, Doo Man
    Kim, Shin Gon
    Lee, Won Young
    Kim, Chong Hwa
    Kim, Chul Sik
    Cho, Dong Hyeok
    Won, Gyu Jang
    Kim, Young Joo
    [J]. DIABETES, 2012, 61 : A161 - A161
  • [2] Intensive Glucose Lowering in Cardiovascular Risk Management - Unsolved Questions
    Shimabukuro, Michio
    Masuzaki, Hiroaki
    Sara, Masataka
    [J]. CIRCULATION JOURNAL, 2012, 76 (03) : 593 - 595
  • [3] Novel lipid-lowering therapies and cardiovascular risk management
    Rizzo, M.
    [J]. CARDIOLOGY, 2013, 126 : 26 - 26
  • [4] The potential of colchicine for lowering the risk of cardiovascular events in type 1 diabetes
    Johansen, Nicklas Jarvela
    Knop, Filip Krag
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2023, 9 (04) : 311 - 317
  • [5] Comparison of Lipid-Lowering Medications and Risk for Cardiovascular Disease in Diabetes
    Ilaria Cavallari
    Alessia Delli Veneri
    Ernesto Maddaloni
    Rosetta Melfi
    Giuseppe Patti
    Nicola Napoli
    Paolo Pozzilli
    Germano Di Sciascio
    [J]. Current Diabetes Reports, 2018, 18
  • [6] Comparison of Lipid-Lowering Medications and Risk for Cardiovascular Disease in Diabetes
    Cavallari, Ilaria
    Delli Veneri, Alessia
    Maddaloni, Ernesto
    Melfi, Rosetta
    Patti, Giuseppe
    Napoli, Nicola
    Pozzilli, Paolo
    Di Sciascio, Germano
    [J]. CURRENT DIABETES REPORTS, 2018, 18 (12)
  • [7] Effects of Physical Activity on Diabetes Management and Lowering Risk for Type 2 Diabetes
    Tompkins, Connie L.
    Soros, Arlette
    Sothern, Melinda S.
    Vargas, Alfonso
    [J]. AMERICAN JOURNAL OF HEALTH EDUCATION, 2009, 40 (05) : 286 - 290
  • [8] Effects of Intensive Glucose Lowering in the Management of Patients With Type 2 Diabetes Mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
    Riddle, Matthew C.
    [J]. CIRCULATION, 2010, 122 (08) : 844 - 846
  • [10] Cardiovascular Risk Management in Type 1 Diabetes
    Teoh, I. H.
    Elisaus, P.
    Schofield, J. D.
    [J]. CURRENT DIABETES REPORTS, 2021, 21 (09)